Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

rediff.com - Nandita Malik - India-EU FTA: Textiles, pharma, engg to get major boost
India-EU FTA: Textiles, pharma, engg to get major boost
Rediff.com

Textiles, pharmaceuticals, chemicals, engineering goods, gems and jewellery exports will receive a boost from the free trade agreement between India and the 27-nation European Union, according to exporters. The conclusion of negotiations for the…

marketbeat.com - Astellas Pharma (OTCMKTS:ALPMY) Reaches New 12-Month High - Should You Buy?
Astellas Pharma (OTCMKTS:ALPMY) Reaches New 12-Month High - Should You Buy?
MarketBeat

Astellas Pharma Inc. (OTCMKTS:ALPMY - Get Free Report) shares hit a new 52-week high during trading on Saturday. The company traded as high as $14.72 and last traded at $14.08, with a volume of 164352 shares trading hands. The stock had previously…

marketbeat.com - Zealand Pharma A/S (OTCMKTS:ZLDPF) Given Average Rating of 'Strong Buy' by Analysts
Zealand Pharma A/S (OTCMKTS:ZLDPF) Given Average Rating of 'Strong Buy' by Analysts
MarketBeat

Zealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report) has received an average rating of 'Strong Buy' from the eight research firms that are currently covering the company, Marketbeat.com reports. Two research analysts have rated the stock with a…

marketbeat.com - Royalty Pharma (NASDAQ:RPRX) Raised to 'Strong-Buy' at Wall Street Zen
Royalty Pharma (NASDAQ:RPRX) Raised to 'Strong-Buy' at Wall Street Zen
MarketBeat

Royalty Pharma (NASDAQ:RPRX - Get Free Report) was upgraded by equities researchers at Wall Street Zen from a 'buy' rating to a 'strong-buy' rating in a report released on Saturday. How Royalty Pharma Prints Cash Without Biotech's Biggest Risks A…

marketbeat.com - Campbell & CO Investment Adviser LLC Invests $2.39 Million in Ascendis Pharma A/S $ASND
Campbell & CO Investment Adviser LLC Invests $2.39 Million in Ascendis Pharma A/S $ASND
MarketBeat

Campbell & CO Investment Adviser LLC acquired a new stake in Ascendis Pharma A/S (NASDAQ:ASND - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor…

deccanchronicle.com - DC Correspondent - Port-Led Growth Takes AP into Top Tier of NITI Aayog's Export Rankings
Port-Led Growth Takes AP into Top Tier of NITI Aayog's Export Rankings
Deccan Chronicle

Visakhapatnam: Andhra Pradesh is witnessing a major shift in its exports' landscape, with pharmaceuticals and textiles emerging as key growth sectors, according to the Export Preparedness Index (EPI) 2024 released by NITI Aayog. The development is…

thecentersquare.com - By Tate Miller | The Center Square contributor - Trump's Great Healthcare Plan 'central' to long-term policy solutions, health sharing ministry says
Trump's Great Healthcare Plan 'central' to long-term policy solutions, health sharing ministry says
The Center Square

(The Center Square) – A health sharing ministry is expressing its support for President Donald Trump's newly announced “Great Healthcare Plan,” stating the plan's promise of transparency and affordability will be…

indianexpress.com - Sohini Ghosh - Why a blockbuster cancer drug could now get dramatically cheaper in India
Why a blockbuster cancer drug could now get dramatically cheaper in India
The Indian Express

Why has Nivolumab been so successful in cancer therapy? To fight an infection, our bodies create proteins known as antibodies. Nivolumab is a monoclonal antibody drug which acts by enhancing the immune response to fight cancerous cells. Monoclonal…

marketbeat.com - Promising Growth Stocks Worth Watching - January 17th
Promising Growth Stocks Worth Watching - January 17th
MarketBeat

Prologis Stock Surges: Why the Rally May Continue Prologis, Teledyne Technologies, Ascendis Pharma A/S, Hamilton Lane, Acadia Realty Trust, Trinity Capital, and BlackRock Innovation and Growth Term Trust are the seven Growth stocks to watch today…

dev.to - Ali-Funk - The 'Virtual Air Gap': Building Fort Knox in AWS
The 'Virtual Air Gap': Building Fort Knox in AWS
DEV Community

Imagine standing in front of your CISO (or a very strict Data Privacy Officer in Germany) and saying: 'We are moving our sensitive patient data to the cloud.' The reaction? Panic. Hyperventilation. 'Never! That needs to be air-gapped! No internet…

thejournal.ie - Eoghan Dalton - EU plans audits of Brazilian beef supply chain as part of efforts to calm Mercosur opposition
EU plans audits of Brazilian beef supply chain as part of efforts to calm Mercosur opposition
TheJournal.ie

THE EU WILL carry out onsite audits of the South American food supply chain before they are exported to countries including Ireland, as part of efforts to sway doubters over its colossal Mercosur trade deal. At least two out of six of these…

theweek.in - Nachiket Kelkar - Beyond legacy: How India's young scions are redefining family businesses
Beyond legacy: How India's young scions are redefining family businesses
tech news

(children of Reliance Industries chairman Mukesh Ambani) In 1931, when the British still ruled the subcontinent, Jamnalal Bajaj established India's first sugar mill—Hindusthan Sugar Mills, the entity that would evolve into Bajaj Hindusthan…

marketbeat.com - Stephens Investment Management Group LLC Trims Stock Holdings in Schrodinger, Inc. $SDGR
Stephens Investment Management Group LLC Trims Stock Holdings in Schrodinger, Inc. $SDGR
MarketBeat

Stephens Investment Management Group LLC decreased its position in Schrodinger, Inc. (NASDAQ:SDGR - Free Report) by 3.0% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The…

marketbeat.com - Novartis AG $NVS Stake Increased by Csenge Advisory Group
Novartis AG $NVS Stake Increased by Csenge Advisory Group
MarketBeat

Csenge Advisory Group boosted its stake in Novartis AG (NYSE:NVS - Free Report) by 58.9% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 29,246…

marketbeat.com - Campbell & CO Investment Adviser LLC Has $1.93 Million Position in Catalyst Pharmaceuticals, Inc. $CPRX
Campbell & CO Investment Adviser LLC Has $1.93 Million Position in Catalyst Pharmaceuticals, Inc. $CPRX
MarketBeat

Campbell & CO Investment Adviser LLC grew its position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX - Free Report) by 124.7% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 97,840 shares…

Receive a Daily briefing on Pharma Industry News

Get Started